RNAC Market Cap & Key Metrics - Cartesian Therapeutics, Inc. logo

RNAC Market Cap & Key Metrics

Cartesian Therapeutics, Inc.

$6.14
+$0.25(+4.24%)
37
Overall
40
Value
40
Tech
31
Quality
How is this score calculated?
Market Cap
$187.29M
Volume
278.09K
52W Range
$5.60 - $11.00
Target Price
$33.67

RNAC market cap is $187.29M. This page lists Cartesian Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.

RNAC Key Metrics

Market cap
$187.29M
EPS estimate, current year
$-2.19
EPS growth, 3-year
-100.00%
Value score
40
Quality score
31
Technical score
40
RNAC revenue, EBITDA and EPS
Fiscal year20252024202320222021
Revenue$400.0K$38.27M$26.00M$110.78M$85.08M
EBITDA-$83.75M-$73.55M-$234.01M$40.05M-$5.63M
EPS$-5.02$-4.48$-49.80$7.20$-6.60
ABCD
1SymbolPriceChangeVol
2RNAC$6.14+4.2%278.09K
3
4
5
6

Get Cartesian Therapeutics, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.